{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:37:30Z","timestamp":1785339450628,"version":"3.55.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1053\/j.jrn.2010.12.004","type":"journal-article","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T21:44:48Z","timestamp":1302817488000},"page":"355-368","source":"Crossref","is-referenced-by-count":43,"title":["Vitamin Status and Needs for People with Stages 3-5 Chronic Kidney Disease"],"prefix":"10.1053","volume":"21","author":[{"given":"Alison L.","family":"Steiber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel D.","family":"Kopple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2010.12.004_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semnephrol.2008.10.002","article-title":"Why is protein-energy wasting associated with mortality in chronic kidney disease?","volume":"29","author":"Kovesdy","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1053\/j.jrn.2010.12.004_bib2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/ajcn\/81.3.543","article-title":"Survival advantages of obesity in dialysis patients","volume":"81","author":"Kalantar-Zadeh","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.jrn.2010.12.004_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1053\/j.ajkd.2005.05.020","article-title":"Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population","volume":"46","author":"Kalantar-Zadeh","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2010.12.004_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1053\/j.ajkd.2007.02.277","article-title":"Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis","volume":"49","author":"Kovesdy","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2010.12.004_bib5","series-title":"Kopple and Massry\u2019s Nutritional Management of Renal Disease","author":"Kopple","year":"2004"},{"key":"10.1053\/j.jrn.2010.12.004_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1024\/0300-9831.70.4.159","article-title":"Assessment of thiamin status in chronic renal failure patients, transplant recipients and hemodialysis patients receiving a multivitamin supplementation","volume":"70","author":"Frank","year":"2000","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1053\/j.jrn.2010.12.004_bib7","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0002-8223(21)03804-9","article-title":"Very-low-protein diets in chronic renal failure: nutrient content and guidelines for supplementation","volume":"85","author":"Piper","year":"1985","journal-title":"J Am Diet Assoc"},{"key":"10.1053\/j.jrn.2010.12.004_bib8","series-title":"Institute of Medicine: For Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, B12, Pantothenic Acid, Biotin\/Choline","year":"2000"},{"key":"10.1053\/j.jrn.2010.12.004_bib9","first-page":"1517","article-title":"Vitamin D insufficiency in a population of healthy western Canadians","volume":"166","author":"Rucker","year":"2002","journal-title":"CMAJ"},{"key":"10.1053\/j.jrn.2010.12.004_bib10","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1046\/j.1523-1755.2000.00014.x","article-title":"Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study","volume":"57","author":"Kopple","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.12.004_bib11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1523-1755.2004.00481.x","article-title":"Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease","volume":"65","author":"Eustace","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.12.004_bib12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1053\/j.ajkd.2007.10.035","article-title":"The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKD","volume":"51","author":"Weiner","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2010.12.004_bib13","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/ndt\/gfn633","article-title":"Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD","volume":"24","author":"Kovesdy","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"5 Suppl 2","key":"10.1053\/j.jrn.2010.12.004_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0272-6386(04)01107-2","article-title":"Dialysis Outcomes and Practice Patterns Study (DOPPS) data on medications in hemodialysis patients","volume":"44","author":"Andreucci","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2010.12.004_bib15","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1001\/jama.2008.892","article-title":"Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States","volume":"300","author":"Qato","year":"2008","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2010.12.004_bib16","series-title":"Institute of Medicine (U.S.), Panel on Dietary Reference Intakes for Electrolytes and Water: DRI, Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate","year":"2005"},{"key":"10.1053\/j.jrn.2010.12.004_bib17","year":"1998"},{"key":"10.1053\/j.jrn.2010.12.004_bib18","series-title":"The Vitamins: Fundamental Aspects in Nutrition and Health","author":"Combs","year":"1998"},{"key":"10.1053\/j.jrn.2010.12.004_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00609694","article-title":"Determination of thiamine in human plasma and its pharmacokinetics","volume":"28","author":"Weber","year":"1985","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1053\/j.jrn.2010.12.004_bib20","first-page":"304","article-title":"Thiamin, riboflavin and pyridoxine status in chronic renal insufficiency","volume":"59","author":"Porrini","year":"1989","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1053\/j.jrn.2010.12.004_bib21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/ajcn\/85.1.218","article-title":"Low and deficient niacin status and pellagra are endemic in postwar Angola","volume":"85","author":"Seal","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.jrn.2010.12.004_bib22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/jren.2003.50025","article-title":"Diet monotony as a correlate of poor nutritional intake among hemodialysis patients","volume":"13","author":"Zimmerer","year":"2003","journal-title":"J Ren Nutr"},{"key":"10.1053\/j.jrn.2010.12.004_bib23","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1523-1755.2004.00482.x","article-title":"Nicotinamide suppresses hyperphosphatemia in hemodialysis patients","volume":"65","author":"Takahashi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.12.004_bib24","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2215\/CJN.04211007","article-title":"A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients","volume":"3","author":"Cheng","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2010.12.004_bib25","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jbspin.2004.07.013","article-title":"Phosphate diabetes, tubular phosphate reabsorption and phosphatonins","volume":"72","author":"Laroche","year":"2005","journal-title":"Joint Bone Spine"},{"key":"10.1053\/j.jrn.2010.12.004_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1525-139X.2008.00426.x","article-title":"Niacin and related compounds for treating hyperphosphatemia in dialysis patients","volume":"21","author":"Berns","year":"2008","journal-title":"Semin Dial"},{"key":"10.1053\/j.jrn.2010.12.004_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.semnephrol.2004.09.006","article-title":"Uric acid and hypertension in adolescents","volume":"25","author":"Feig","year":"2005","journal-title":"Semin Nephrol"},{"key":"10.1053\/j.jrn.2010.12.004_bib28","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ki.1981.69","article-title":"Daily requirement for pyridoxine supplements in chronic renal failure","volume":"19","author":"Kopple","year":"1981","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.12.004_bib29","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.thromres.2006.12.011","article-title":"Abnormalities of homocysteine and B vitamins in the nephrotic syndrome","volume":"120","author":"Podda","year":"2007","journal-title":"Thromb Res"},{"issue":"Suppl 4","key":"10.1053\/j.jrn.2010.12.004_bib30","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1111\/j.1440-1797.2005.00466.x","article-title":"The CARI guidelines. Biochemical and haematological targets guidelines. Haemoglobin","volume":"10","author":"Pollock","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"10.1053\/j.jrn.2010.12.004_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.clnu.2006.01.023","article-title":"ESPEN guidelines on enteral nutrition: adult renal failure","volume":"25","author":"Cano","year":"2006","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"key":"10.1053\/j.jrn.2010.12.004_bib32","doi-asserted-by":"crossref","unstructured":"Pollock C, Voss D, Hodson E, et al: The CARI guidelines. Nutrition and growth in kidney disease. Nephrology (Carlton) 10(Suppl 5):S177-S230","DOI":"10.1111\/j.1440-1797.2005.00506.x"},{"key":"10.1053\/j.jrn.2010.12.004_bib33","first-page":"339","article-title":"Intestinal absorption of 5-methyltetrahydrofolate in experimental uremia","volume":"6","author":"Said","year":"1984","journal-title":"Acta Vitaminol Enzymol"},{"key":"10.1053\/j.jrn.2010.12.004_bib34","first-page":"172","article-title":"Erythropoiesis in patients undergoing regular dialysis treatment without transfusion","volume":"5","author":"Mackenzie","year":"1968","journal-title":"Proc Eur Dial Transplant Assoc"},{"key":"10.1053\/j.jrn.2010.12.004_bib35","first-page":"834","article-title":"Inhibition of the membrane transport of folates by anions retained in uremia","volume":"86","author":"Jennette","year":"1975","journal-title":"J Lab Clin Med"},{"key":"10.1053\/j.jrn.2010.12.004_bib36","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1373\/clinchem.2008.114389","article-title":"Liquid chromatography-tandem mass spectrometry analysis of folate and folate catabolites in human serum","volume":"55","author":"Hannisdal","year":"2009","journal-title":"Clin Chem"},{"key":"10.1053\/j.jrn.2010.12.004_bib37","first-page":"133","article-title":"Persistent anemia associated with reduced serum vitamin B12 levels in patients undergoing regular hemodialysis therapy","volume":"11","author":"Bastow","year":"1979","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.jrn.2010.12.004_bib38","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.298.10.1163","article-title":"Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial","volume":"298","author":"Jamison","year":"2007","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2010.12.004_bib39","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1523-1755.2005.00234.x","article-title":"Homocysteine in chronic kidney disease: effect of low protein diet and repletion with B vitamins","volume":"67","author":"Menon","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.12.004_bib40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ndt\/gfl510","article-title":"The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation","volume":"22","author":"Suliman","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2010.12.004_bib41","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1523-1755.2002.00144.x","article-title":"Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients","volume":"61","author":"Mallamaci","year":"2002","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.12.004_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.ajkd.2008.06.016","article-title":"Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD","volume":"53","author":"Nanayakkara","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2010.12.004_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1479164110366053","article-title":"Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus","volume":"7","author":"Anderssohn","year":"2010","journal-title":"Diab Vasc Dis Res"},{"key":"10.1053\/j.jrn.2010.12.004_bib44","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ndt\/gfm485","article-title":"Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease\u2014results of the renal Hope-2 study","volume":"23","author":"Mann","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2010.12.004_bib45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cca.2008.05.018","article-title":"Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients","volume":"395","author":"Valli","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1053\/j.jrn.2010.12.004_bib46","doi-asserted-by":"crossref","unstructured":"House AA, Eliasziw M, Cattran DC, et al: Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA 303:1603-1609","DOI":"10.1001\/jama.2010.490"},{"key":"10.1053\/j.jrn.2010.12.004_bib47","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.1161\/01.CIR.0000165142.37711.E7","article-title":"Cardiology patient pages. Homocysteine and MTHFR mutations: relation to thrombosis and coronary artery disease","volume":"111","author":"Varga","year":"2005","journal-title":"Circulation"},{"key":"10.1053\/j.jrn.2010.12.004_bib48","year":"2000"},{"key":"10.1053\/j.jrn.2010.12.004_bib49","first-page":"95","article-title":"Vitamin C with metabolites reduce oxalate levels compared to ascorbic acid: a preliminary and novel clinical urologic finding","volume":"29","author":"Moyad","year":"2009","journal-title":"Urol Nurs"},{"key":"10.1053\/j.jrn.2010.12.004_bib50","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1054\/clnu.1999.0130","article-title":"Expert Working Group report on nutrition in adult patients with renal insufficiency (part 1 of 2)","volume":"19","author":"Toigo","year":"2000","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"key":"10.1053\/j.jrn.2010.12.004_bib51","series-title":"Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids","author":"Intakes CoDR","year":"2000"},{"key":"10.1053\/j.jrn.2010.12.004_bib52","year":"2001"},{"key":"10.1053\/j.jrn.2010.12.004_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-511X-7-29","article-title":"Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver","volume":"7","author":"Frey","year":"2008","journal-title":"Lipids Health Dis"},{"key":"10.1053\/j.jrn.2010.12.004_bib54","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/ajkd.2002.31389","article-title":"Relationship of serum antioxidant vitamins to serum creatinine in the US population","volume":"39","author":"Chen","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.jrn.2010.12.004_bib55","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1172\/JCI106741","article-title":"The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma","volume":"50","author":"Smith","year":"1971","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jrn.2010.12.004_bib56","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/bmj.3.5979.352","article-title":"Hypervitaminosis A accompanying advanced chronic renal failure","volume":"3","author":"Yatzidis","year":"1975","journal-title":"BMJ"},{"key":"10.1053\/j.jrn.2010.12.004_bib57","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1042\/cs0650619","article-title":"Vitamin A and its transport proteins in patients with chronic renal failure receiving maintenance haemodialysis and after renal transplantation","volume":"65","author":"Kelleher","year":"1983","journal-title":"Clin Sci (Lond)"},{"key":"10.1053\/j.jrn.2010.12.004_bib58","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000112413","article-title":"Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease","volume":"28","author":"Karamouzis","year":"2008","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.jrn.2010.12.004_bib59","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1196\/annals.1331.041","article-title":"Vitamin E in uremia and dialysis patients","volume":"1031","author":"Galli","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.jrn.2010.12.004_bib60","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1523-1755.2004.00513.x","article-title":"Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study","volume":"65","author":"Mann","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.12.004_bib61","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1001\/jama.293.11.1338","article-title":"Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial","volume":"293","author":"Lonn","year":"2005","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2010.12.004_bib62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality","volume":"142","author":"Miller","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jrn.2010.12.004_bib63","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1001\/jama.1987.03400140078028","article-title":"Coagulopathy caused by vitamin K deficiency in critically ill, hospitalized patients","volume":"258","author":"Alperin","year":"1987","journal-title":"JAMA"},{"key":"10.1053\/j.jrn.2010.12.004_bib64","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2215\/CJN.06420909","article-title":"Vitamins K and D status in stages 3-5 chronic kidney disease","volume":"5","author":"Holden","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2010.12.004_bib65","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.semnephrol.2008.10.010","article-title":"Vitamin D therapy for chronic kidney disease","volume":"29","author":"Bhan","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1053\/j.jrn.2010.12.004_bib66","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1159\/000080087","article-title":"Achieving K\/DOQI laboratory target values for bone and mineral metabolism: an uphill battle","volume":"24","author":"Al Aly","year":"2004","journal-title":"Am J Nephrol"},{"key":"10.1053\/j.jrn.2010.12.004_bib67","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4158\/EP.14.1.18","article-title":"Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease","volume":"14","author":"Andress","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1053\/j.jrn.2010.12.004_bib68","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ndt\/17.2.233","article-title":"Serum osteoprotegerin and renal osteodystrophy","volume":"17","author":"Coen","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2010.12.004_bib69","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1681\/ASN.2009050494","article-title":"Is calcitriol life-protective for patients with chronic kidney disease?","volume":"20","author":"Thadhani","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2010.12.004_bib70","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ki.2008.168","article-title":"Vitamin D levels and early mortality among incident hemodialysis patients","volume":"74","author":"Mailliez","year":"2008","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.12.004_bib71","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin D levels and patient outcome in chronic kidney disease","volume":"75","author":"Ravani","year":"2009","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.12.004_bib72","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ki.2009.288","article-title":"Chronic kidney disease, hypo vitaminosis D, and mortality in the United States","volume":"76","author":"Mehrotra","year":"2009","journal-title":"Kidney Int"},{"key":"10.1053\/j.jrn.2010.12.004_bib73","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.167.11.1159","article-title":"Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey","volume":"167","author":"Martins","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.jrn.2010.12.004_bib74","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/sj.bjc.6605658","article-title":"Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies","volume":"102","author":"Bao","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1053\/j.jrn.2010.12.004_bib75","doi-asserted-by":"crossref","first-page":"c58","DOI":"10.1159\/000151534","article-title":"Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment","volume":"110","author":"Jean","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.jrn.2010.12.004_bib76","first-page":"S1","article-title":"Kidney Disease, Improving Global Outcomes (KDIGO) CKD-MBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.jrn.2010.12.004_bib77","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1373\/clinchem.2009.139253","article-title":"The D-lemma: to screen or not to screen for 25-hydroxyvitamin D concentrations","volume":"56","author":"Holick","year":"2010","journal-title":"Clin Chem"},{"key":"10.1053\/j.jrn.2010.12.004_bib78","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7326\/0003-4819-147-12-200712180-00004","article-title":"Meta-analysis: vitamin D compounds in chronic kidney disease","volume":"147","author":"Palmer","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jrn.2010.12.004_bib79","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(08)60251-2","article-title":"Activated vitamin D sterols in kidney disease","volume":"371","author":"Thadhani","year":"2008","journal-title":"Lancet"},{"key":"10.1053\/j.jrn.2010.12.004_bib80","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/jc.2007-2308","article-title":"Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D","volume":"93","author":"Holick","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.jrn.2010.12.004_bib81","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5414\/CNP73276","article-title":"Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K\/DOQI treatment guidelines adequate?","volume":"73","author":"Qunibi","year":"2010","journal-title":"Clin Nephrol"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227611000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051227611000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T18:01:32Z","timestamp":1637517692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051227611000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1051227611000069"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2010.12.004","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}